Global dissemination of a multidrug resistant Escherichia coli clone

Significance Escherichia coli sequence type 131 (ST131) is a globally disseminated multidrug-resistant clone associated with human urinary tract and bloodstream infections. Here, we have used genome sequencing to map the temporal and spatial relationship of a large collection of E. coli ST131 strains isolated from six distinct geographical regions across the world. We show that E. coli ST131 strains are distinct from other extraintestinal pathogenic E. coli and arose from a single progenitor strain prior to the year 2000. Escherichia coli sequence type 131 (ST131) is a globally disseminated, multidrug resistant (MDR) clone responsible for a high proportion of urinary tract and bloodstream infections. The rapid emergence and successful spread of E. coli ST131 is strongly associated with several factors, including resistance to fluoroquinolones, high virulence gene content, the possession of the type 1 fimbriae FimH30 allele, and the production of the CTX-M-15 extended spectrum β-lactamase (ESBL). Here, we used genome sequencing to examine the molecular epidemiology of a collection of E. coli ST131 strains isolated from six distinct geographical locations across the world spanning 2000–2011. The global phylogeny of E. coli ST131, determined from whole-genome sequence data, revealed a single lineage of E. coli ST131 distinct from other extraintestinal E. coli strains within the B2 phylogroup. Three closely related E. coli ST131 sublineages were identified, with little association to geographic origin. The majority of single-nucleotide variants associated with each of the sublineages were due to recombination in regions adjacent to mobile genetic elements (MGEs). The most prevalent sublineage of ST131 strains was characterized by fluoroquinolone resistance, and a distinct virulence factor and MGE profile. Four different variants of the CTX-M ESBL–resistance gene were identified in our ST131 strains, with acquisition of CTX-M-15 representing a defining feature of a discrete but geographically dispersed ST131 sublineage. This study confirms the global dispersal of a single E. coli ST131 clone and demonstrates the role of MGEs and recombination in the evolution of this important MDR pathogen.

[1]  C. Whitfield.  Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. , 2006, Annual review of biochemistry.

[2]  B. Chait,et al.  Escherichia coli condensin MukB stimulates topoisomerase IV activity by a direct physical interaction , 2010, Proceedings of the National Academy of Sciences.

[3]  Julian Parkhill,et al.  Evolution of MRSA During Hospital Transmission and Intercontinental Spread , 2010, Science.

[4]  J. Cheesbrough,et al.  Major Uropathogenic Escherichia coli Strain Isolated in the Northwest of England Identified by Multilocus Sequence Typing , 2008, Journal of Clinical Microbiology.

[5]  E. Denamur,et al.  Virulence of Escherichia coli Clinical Isolates in a Murine Sepsis Model in Relation to Sequence Type ST131 Status, Fluoroquinolone Resistance, and Virulence Genotype , 2012, Infection and Immunity.

[6]  N. Woodford,et al.  Complete Nucleotide Sequences of Plasmids pEK204, pEK499, and pEK516, Encoding CTX-M Enzymes in Three Major Escherichia coli Lineages from the United Kingdom, All Belonging to the International O25:H4-ST131 Clone , 2009, Antimicrobial Agents and Chemotherapy.

[7]  M. Hattori,et al.  Complete Genome Sequence of the Wild-Type Commensal Escherichia coli Strain SE15, Belonging to Phylogenetic Group B2 , 2009, Journal of bacteriology.

[8]  Mark J. Pallen,et al.  The Flag-2 Locus, an Ancestral Gene Cluster, Is Potentially Associated with a Novel Flagellar System from Escherichia coli , 2005, Journal of bacteriology.

[9]  J. Blanco,et al.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.

[10]  J. Harel,et al.  Development and Validation of an Oligonucleotide Microarray for Detection of Multiple Virulence and Antimicrobial Resistance Genes in Escherichia coli , 2006, Applied and Environmental Microbiology.

[11]  J. Burton,et al.  Rapid Pneumococcal Evolution in Response to Clinical Interventions , 2011, Science.

[12]  Wei Qian,et al.  Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. , 2000, Molecular biology and evolution.

[13]  Maliha Aziz,et al.  Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. , 2013, The Journal of infectious diseases.

[14]  J. Corander,et al.  Phylogeographic variation in recombination rates within a global clone of methicillin-resistant Staphylococcus aureus , 2012, Genome Biology.

[15]  J. Blanco,et al.  Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). , 2011, The Journal of antimicrobial chemotherapy.

[16]  E. Birney,et al.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.

[17]  J. Corander,et al.  Detection of recombination events in bacterial genomes from large population samples , 2011, Nucleic acids research.

[18]  M. Kuskowski,et al.  Escherichia coli Sequence Type ST131 as an Emerging Fluoroquinolone-Resistant Uropathogen among Renal Transplant Recipients , 2009, Antimicrobial Agents and Chemotherapy.

[19]  S. Wray,et al.  Escherichia coli–Mediated Impairment of Ureteric Contractility Is Uropathogenic E. coli Specific , 2012, The Journal of infectious diseases.

[20]  G. Peirano,et al.  Characteristics of NDM-1-Producing Escherichia coli Isolates That Belong to the Successful and Virulent Clone ST131 , 2011, Antimicrobial Agents and Chemotherapy.

[21]  Nicola K. Petty,et al.  BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons , 2011, BMC Genomics.

[22]  T. Wells,et al.  Autotransporters of Escherichia coli: a sequence-based characterization. , 2010, Microbiology.

[23]  C. Lohse,et al.  Escherichia coli Sequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts , 2013, Infection Control & Hospital Epidemiology.

[24]  S. Beatson,et al.  A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. , 2013, The Journal of infectious diseases.

[25]  Sri H. Ramarathinam,et al.  Discovery of an archetypal protein transport system in bacterial outer membranes , 2012, Nature Structural &Molecular Biology.

[26]  D. Rasko,et al.  Defining Genomic Islands and Uropathogen-Specific Genes in Uropathogenic Escherichia coli , 2007, Journal of bacteriology.

[27]  M. Kuskowski,et al.  Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  F. Baquero,et al.  Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.

[29]  E. Denamur,et al.  Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. , 2009, The Journal of antimicrobial chemotherapy.

[30]  D. W. Kim,et al.  Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe , 2012, Nature Genetics.

[31]  M. Kaufmann,et al.  UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. , 2008, The Journal of antimicrobial chemotherapy.

[32]  Nicola K. Petty,et al.  Insights into a Multidrug Resistant Escherichia coli Pathogen of the Globally Disseminated ST131 Lineage: Genome Analysis and Virulence Mechanisms , 2011, PloS one.

[33]  Nicholas M. Luscombe,et al.  Evidence of non-random mutation rates suggests an evolutionary risk management strategy , 2012, Nature.

[34]  Daniel Falush,et al.  Impact of homologous and non-homologous recombination in the genomic evolution of Escherichia coli , 2012, BMC Genomics.

[35]  N. Perna,et al.  progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement , 2010, PloS one.

[36]  J. Corander,et al.  The Evolutionary Path to Extraintestinal Pathogenic, Drug-Resistant Escherichia coli Is Marked by Drastic Reduction in Detectable Recombination within the Core Genome , 2013, Genome biology and evolution.

[37]  Steven Salzberg,et al.  Mugsy: fast multiple alignment of closely related whole genomes , 2010, Bioinform..

[38]  E. Denamur,et al.  The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. , 2008, The Journal of antimicrobial chemotherapy.

[39]  A. Danchin,et al.  Organised Genome Dynamics in the Escherichia coli Species Results in Highly Diverse Adaptive Paths , 2009, PLoS genetics.

[40]  R. Cantón,et al.  The CTX-M β-lactamase pandemic , 2006 .

[41]  D. Paterson,et al.  Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. , 2011, The Journal of antimicrobial chemotherapy.

[42]  Tiruvayipati Suma Avasthi,et al.  Genome of Multidrug-Resistant Uropathogenic Escherichia coli Strain NA114 from India , 2011, Journal of bacteriology.

[43]  C. Constantinidou,et al.  Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections. , 2012, The Journal of antimicrobial chemotherapy.

[44]  C. Alteri,et al.  Quantitative Profile of the Uropathogenic Escherichia coli Outer Membrane Proteome during Growth in Human Urine , 2007, Infection and Immunity.

[45]  A. Robicsek,et al.  Comparison of Escherichia coli ST131 Pulsotypes, by Epidemiologic Traits, 1967–2009 , 2012, Emerging infectious diseases.

[46]  L. Price,et al.  Role of Homologous Recombination in Adaptive Diversification of Extraintestinal Escherichia coli , 2012, Journal of bacteriology.

[47]  Mitchell J. Sullivan,et al.  Easyfig: a genome comparison visualizer , 2011, Bioinform..

[48]  Nicola K. Petty,et al.  Chaperone-Usher Fimbriae of Escherichia coli , 2013, PloS one.

[49]  Lucian Ilie,et al.  SHRiMP2: Sensitive yet Practical Short Read Mapping , 2011, Bioinform..

[50]  C. Combescure,et al.  Virulence Potential and Genomic Mapping of the Worldwide Clone Escherichia coli ST131 , 2012, PloS one.

[51]  Alexandros Stamatakis,et al.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models , 2006, Bioinform..

[52]  S. Beatson,et al.  The Serum Resistome of a Globally Disseminated Multidrug Resistant Uropathogenic Escherichia coli Clone , 2013, PLoS genetics.

[53]  Matthew Berriman,et al.  Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database , 2008, Bioinform..

[54]  J. Cheesbrough,et al.  Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. , 2012, The Journal of antimicrobial chemotherapy.